NCT05294874

Brief Summary

Background: Standing and walking serve an individual's basic need to move from place to place, and both are the most common activities that people do on a daily basis. Aim: to investigate the combined effect of botulinum toxin A (BoNT-A) injection and ankle weight on the gait of diplegic children who are using Ankle foot orthoses.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 14, 2021

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 25, 2021

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 6, 2022

Completed
18 days until next milestone

First Posted

Study publicly available on registry

March 24, 2022

Completed
Last Updated

March 24, 2022

Status Verified

March 1, 2022

Enrollment Period

4 months

First QC Date

March 6, 2022

Last Update Submit

March 15, 2022

Conditions

Keywords

gaitdiplegiaankle weightbotox injection

Outcome Measures

Primary Outcomes (2)

  • measurement of knee excursion during gait

    evaluation of knee flexion range of motion during gait using two dimension gait analysis.

    after 3 months of the treatment program.

  • evaluation of spasticity: modified ashowrth scale scores

    hamstring and calf muscles evaluation of spasticity through passive movement .the score ranged from 0 ( nearly normal) to 5 (rigid in flexion or extension)

    after 3 months of the treatment program.

Secondary Outcomes (1)

  • electromyography to asses spasticity in hamstring and calf muscles

    after 3 months of the treatment program.

Study Arms (3)

classical gait training

ACTIVE COMPARATOR

physical therapy exercises including classical gait training

Other: gait training

classical gait training using ankle weight

ACTIVE COMPARATOR

physical therapy exercises including classical gait training while using ankle weight

Other: gait training

gait training using ankle weight after botulinum toxin injection

EXPERIMENTAL

physical therapy exercises including classical gait training while using ankle weight and with BOTOX injection

Other: gait training

Interventions

walking forward, sideway and backward walking on balance board

Also known as: rehabilitation
classical gait trainingclassical gait training using ankle weightgait training using ankle weight after botulinum toxin injection

Eligibility Criteria

Age5 Years - 10 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • diagnosed as spastic diplegia.
  • They were able to follow simple verbal instructions.
  • The use of Ankle Foot Orthoses.
  • Spasticity grade of 1+ or 2 in both calf and hamstring muscles according to modified Ashworth's scale (MAS).
  • level I or II on the Gross Motor Function Classification System (GMFCS).

You may not qualify if:

  • fixed contractures or deformities in the lower limbs.
  • surgical orthopedic intervention.
  • Botulinum A injection or use of neuromuscular blockers in the previous 6 months before the start of study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Physical Therapy,Cairo University

Cairo, Giza Governorate, 02, Egypt

Location

MeSH Terms

Conditions

Cerebral Palsy

Interventions

Rehabilitation

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

AftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Nahla mohamed, phd

    Cairo University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer physical therapy

Study Record Dates

First Submitted

March 6, 2022

First Posted

March 24, 2022

Study Start

July 15, 2021

Primary Completion

November 14, 2021

Study Completion

November 25, 2021

Last Updated

March 24, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will share

tables and figures of statistical analysis published

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
after publication of the results
Access Criteria
through contact the authors

Locations